Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer's diseases: Evaluation in aspects of in silico and in vitro experiments

dc.contributor.author Yilmaz, Anil
dc.contributor.author Koca, Murat
dc.contributor.author Ercan, Selami
dc.contributor.author Acar, Ozden Ozgun
dc.contributor.author Boga, Mehmet
dc.contributor.author Sen, Alaattin
dc.contributor.author Kurt, Adnan
dc.contributor.authorID 0000-0002-8444-376X en_US
dc.contributor.department AGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Moleküler Biyoloji ve Genetik Bölümü en_US
dc.contributor.institutionauthor Sen, Alaattin
dc.date.accessioned 2024-08-19T07:15:50Z
dc.date.available 2024-08-19T07:15:50Z
dc.date.issued 2024 en_US
dc.description.abstract Alzheimer disease (AD) and multiple sclerosis (MS) are inflammatory neurological disorders. The main symptom of AD is dementia, and the main symptoms of MS are vertigo, sexual dysfunction, cognitive problems, and fatigue. Today, millions of people are affected by AD and MS, and the number is growing day by day. However, there are not any accurate remedies for both disorders. For this reason, discovering novel drug molecules against neurological disorders such as AD and MS is essential and precious. Oximes and benzofurans exhibit many pharmacological effects including anti-inflammatory and neurological activities. Thus, several novel compounds bearing oxime and benzofuran chemical cores were designed and synthesized, and their in vitro anticholinesterase activities were investigated in our previous study. A number of the synthesized molecules showed excellent anticholinesterase activity against both AChE and BChE enzymes. The mentioned study constituted a background for this study. In this study, we picked different chemical skeletons among all the synthesized molecules to conduct further in silico and in vitro experiments. In order to support our in vitro anticholinesterase findings, we also examined in silico anti-Alzheimer activity of the selected molecules. In addition, in silico and in vitro activities against MS disease of the synthesized molecules were investigated. Molecule 4 extraordinarily showed outstanding activity against AD disease both in silico and in vitro, as well as in silico activity against MS disease. This feature makes molecule 4 a possible drug lead molecule which is very limited in the market. On the other hand, molecule 1, a less substituted oxime skeleton, demonstrated the strongest in vitro activity against MS disease through in vitro anti-inflammatory effect. As an observation, molecule 4 was determined to be the most promising molecule to focus on in the further steps. en_US
dc.identifier.endpage 13 en_US
dc.identifier.issn 00222860
dc.identifier.startpage 1 en_US
dc.identifier.uri https://doi.org/10.1016/j.molstruc.2024.139193
dc.identifier.uri https://hdl.handle.net/20.500.12573/2327
dc.identifier.volume 1318 en_US
dc.language.iso eng en_US
dc.publisher ELSEVIER en_US
dc.relation.isversionof 10.1016/j.molstruc.2024.139193 en_US
dc.relation.journal Journal of Molecular Structure en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject anti-Alzheimer en_US
dc.subject Anticholinesterase en_US
dc.subject In silico en_US
dc.subject In vitro en_US
dc.subject Multiple sclerosis en_US
dc.subject Oxime en_US
dc.title Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer's diseases: Evaluation in aspects of in silico and in vitro experiments en_US
dc.type article en_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S0022286024017101-main.pdf
Size:
16.17 MB
Format:
Adobe Portable Document Format
Description:
Makale Dosyası

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: